LEGN vs. ADVM

In the year-to-date period, LEGN achieves a -1.54% return, which is significantly higher than ADVM's -33.19% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Legend Biotech Corporation (LEGN) and Adverum Biotechnologies, Inc. (ADVM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current LEGN Sharpe Ratio is -0.59, which is higher than the ADVM Sharpe Ratio of -0.97. The chart below compares the historical Sharpe Ratios of LEGN and ADVM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither LEGN nor ADVM has paid dividends to shareholders.

The maximum LEGN drawdown since its inception was -60.46%, smaller than the maximum ADVM drawdown of -99.55%. Use the drawdown chart below to compare losses from any high point for LEGN and ADVM. For additional features, visit the drawdowns tool.

The current volatility for Legend Biotech Corporation (LEGN) is 13.25%, while Adverum Biotechnologies, Inc. (ADVM) has a volatility of 26.89%. This indicates that LEGN experiences smaller price fluctuations and is considered to be less risky than ADVM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Legend Biotech Corporation and Adverum Biotechnologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.